bay h 4502 and Candidiasis, Vulvovaginal

bay h 4502 has been researched along with Candidiasis, Vulvovaginal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaplan, B; Neri, A; Rabinerson, D; Royburt, M1
Basi, N; Dronda, MA; Forn, J; GarcĂ­a Rafanell, J; Merlos, M; Torres, JM; Zapatero, MI1

Trials

1 trial(s) available for bay h 4502 and Candidiasis, Vulvovaginal

ArticleYear
Once-daily fluocinonide-bifonazole combination for the treatment of vulvar itching and vulvovaginal candidiasis. Preliminary study.
    Clinical and experimental obstetrics & gynecology, 1996, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Combinations; Female; Fluocinonide; Humans; Imidazoles; Middle Aged; Ointments; Treatment Outcome; Vulvovaginitis

1996

Other Studies

1 other study(ies) available for bay h 4502 and Candidiasis, Vulvovaginal

ArticleYear
In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:6

    Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fungi; Guinea Pigs; Imidazoles; Male; Microbial Sensitivity Tests; Mycoses; Rats; Rats, Wistar; Tinea

1992